REFERENCES
- Mathé G, Kidani Y, Segiguchi M et al. Oxalato-platinum or L-OHP, a third generation platinum complex. An experi-mental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum. Biomed Pharmacother 1989; 43: 237–50.
- Raymond E, Chaney S, Taamma A et al. Preclinical and clinical studies of oxaliplatin. Ann Oncol 1998; 9: 1053–71.
- Lévi F, Misset JL, Brienza S et al. A chronopharmaco-logic phase II clinical trial with fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Cancer 1992; 69: 893–900.
- Bertheault-Cvitkovic F, Jami A, Itzhaki M et al. Biweekly intesified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 1996; 14: 2950–8.
- DeGramont A, Vignoud J, Tournigand C et al. Oxaliplatin with high dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer 1997; 33A, 214–9.
- Brienza S, Fandi A, Hugret F et al. Neurotoxicity (NTX) of long term oxaliplatin (L-OHP) therapy. Proc Annual Meet Am Assoc Cancer Res 1993; 34: 406.
- Kalien KJ, Hofman MA, Timm A, Godderz W, Galle PR, Heike M. Weekly oxaliplatin, high-dose infusional 5-fluo-rouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma. Z Gastroenterol 2000; 38: 153–7.
- Brienza S, Bensmaine A, Soulié P et al. Oxaliplatin added to 5-fluorouracil-based therapy (5-FU+FA) in the treat-ment of 5-FU-pretreated patients with advanced colorectal car-cinoma (ACRC). Results from the European compassionate-use program. Ann Oncol 1999; 10: 1311–6.
- Machover D, Diaz-Rubio E, DeGramont A et al. Two consecutive phase II studies of oxaliplatin (L-OHP) for treat-ment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol 1996; 7: 95–8.
- Médioni J, Coulon MA, Morere JF, Hennebelle F, Piperno-Neumann S, Breau JL. Anaphylaxis after oxaliplatin. Ann Oncol 1999; 10: 610.
- Sanofi Research. Clinical investigator's brochure SR96669, oxaliplatin. Sanofi Research, 11th of May 1998, Gentilly cedex, France.